Procleix assays expand your blood screening with a comprehensive NAT assay portfolio.
Offer advanced blood screening with the NAT solutions portfolio including screening of: HIV-1, HIV-2, HCV, HBV, WNV, Parvovirus B19, HAV, HEV, Dengue Virus, Zika Virus, Babesia, and Plasmodium.
More results, faster
Efficiently manage your workload with test results within 3.5 hours then additional run results every 5 minutes after. From a single sample, process up to four assays on one system at the same time.
The costs for recruiting donors and waste disposal are often overlooked. The Procleix assay portfolio helps reduce the cost of NAT screening with less waste, fewer moving parts and liquid waste that can be poured down the drain.
Comprehensive Assay Menu
The Procleix assay portfolio contains an expanding menu of assays for the current NAT testing needs around the world. Isothermal TMA technology eliminates the need for thermocycling, which is used in PCR.